Fig. 5.
The effect of PSC-833 on blast survival in pgp+ve and pgp−ve patient samples.
Leukemic patient sample viability after treatment with PSC-833 in 18-hour culture in 1% FCS without growth factors. Thick lines represent responses of pgp+ve blasts, and thin lines represent pgp−ve blasts.